FIFTH AMENDMENT TO THE LICENSE AGREEMENTLicense Agreement • May 9th, 2013 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)
This FIFTH AMENDMENT TO THE LICENSE AGREEMENT (the “Fifth Amendment”) is made and entered into as of April 1, 2013 (the “Fifth Amendment Effective Date”), by and between SANGAMO BIOSCIENCES, INC., a Delaware corporation having its principal place of business at Point Richmond Tech Center, 501 Canal Boulevard, Suite A100, Richmond, California 94804 (“Sangamo”), and SIGMA-ALDRICH CO., LLC, a Delaware limited liability company having its principal place of business at 3050 Spruce Street, St. Louis, MO 63103 (“Sigma”). Sigma and Sangamo are individually referred to herein as a “Party” or collectively as the “Parties.”
